Classifications des gastrites chroniques
Mots-clés :
Gastrite, atrophie, métaplasie intestinale, classificationsRésumé
Les gastrites chroniques (GC) sont des affections inflammatoires chroniques de la muqueuse gastrique, dont le diagnostic repose sur l’examen anatomo-pathologique.
Elles sont fréquentes et couvrent une partie non négligeable de l’activité quotidienne des pathologistes.Leur origine est souvent infectieuse, particulièrement l’infection à HélicobacterPylori.
Plusieurs classifications des GC ont été proposées mais afin d’aboutir à une standardisation dans la rédaction des comptes rendus anatomo-pathologiques des biopsies gastriques, les pathologistes suivent actuellement les recommandations de la classification de Sydney modifiée.
Les stades OLGA (Operative Link for GastritisAssessment) et OLGIM (Operative Link for Gastritis Intestinal MetaplasiaAssessment) sont de plus en plus utilisées puisqu’ils permettent de répondre aux attentes des cliniciens en sélectionnant, sur des bases morphologiques, les formes de GC à « haut risque » qui nécessiteraient une surveillance particulière.
Cette mise au point vise à effectuer une revue des différentes classifications des GC qui sont actuellement proposées aux pathologistes.
Téléchargements
Références
Valencia-Parparcen J, Carbonell L, Bruni-Celli B, Madureri V. Diagnosis of gastritis: a review and a report of the use of blind biopsy. Am J Dig Dis 1961;6:813‑32.
Misiewicz JJ. The Sydney System: a new classification of gastritis. Introduction. J Gastroenterol Hepatol 1991;6(3):207‑8.
Whitehead R, Truelove SC, Gear MW. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol 1972;25(1):1‑11.
Lambert R. Chronic gastritis. A critical study of the progressive atrophy of the gastric mucosa. Digestion 1972;7(1):83‑126.
Schindler R. What does gastroscopy offer in the early diagnosis of cancer of the stomach? Calif Med 1947;66(3):110‑6.
Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973;18(5):426‑40.
Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988;83(5):504‑9.
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1(8336):1273‑5.
Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6(3):209‑22.
Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20(10):1161‑81.
Dixon MF, Genta RM, Yardley JH, Correa P. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter 1997;2(1 Suppl):17-24.
Varbanova M, Wex T, Jechorek D, Röhl FW, Langner C, Selgrad M, et al. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment. J Clin Pathol 2016;69(1):19‑25.
Isajevs S, Liepniece-Karele I, Janciauskas D, Moisejevs G, Funka K, Kikuste I, et al. The effect of incisura angularis biopsy sampling on the assessment of gastritis stage. Eur J Gastroenterol Hepatol 2014;26(5):510‑3.
Rokkas T, Rokka A, Portincasa P.A systematic review and meta-analysis of the role of Helicobacter Pylori eradication in preventing gastric cancer.Ann Gastroenterol. 2017;30(4):414-23
Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44(1):74‑94.
Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40(8):650‑8.
Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010;71(7):1150‑8.
Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16(7):1249‑59.
Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010;31(10):1104‑11.
Offerhaus GJ, Price AB, Haot J, ten Kate FJ, Sipponen P, Fiocca R, et al. Observer agreement on the grading of gastric atrophy. Histopathology 1999;34(4):320‑5.
Rugge M, Fassan M, Pizzi M, Farinati F, Sturniolo GC, Plebani M, et al. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol 2011;17(41):4596‑601.
Zhou Y, Li H-Y, Zhang J-J, Chen X-Y, Ge Z-Z, Li X-B. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J Gastroenterol 2016;22(13):3670‑8.
Isajevs S, Liepniece-Karele I, Janciauskas D, Moisejevs G, Putnins V, Funka K, et al. Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch 2014;464(4):403‑7.
Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, Wen X, Lopes C, Figueiredo C, et al. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther 2012;35(12):1451‑9.
Satoh K, Osawa H, Yoshizawa M, Nakano H, Hirasawa T, Kihira K, et al. Assessment of atrophic gastritis using the OLGA system. Helicobacter 2008;13(3):225‑9.
Gurzu S, Orlowska J, Sugimura H, Bara T, Szentirmay Z, Januszewicz W, Bara T Jr, Szederjesi J, Jung I. Immunohistochemical features and staging of early gastric cancer.Arch Med Sci 2017;13(6):1373-82.
den Hoed CM, Holster IL, Capelle LG, de Vries AC, den Hartog B, Ter Borg F, et al. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy 2013;45(4):249‑56.
